Accès à distance ? S'identifier sur le proxy UCLouvain
HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome
Primary tabs
Document type | Article de périodique (Journal article) – Article de recherche |
---|---|
Access type | Accès restreint |
Publication date | 2013 |
Language | Anglais |
Journal information | "Cardiovascular Research" - Vol. 99, no. 1, p. 44-54 (2013) |
Peer reviewed | yes |
Publisher | Oxford University Press ((United Kingdom) Oxford) |
issn | 0008-6363 |
e-issn | 1755-3245 |
Publication status | Publié |
Affiliations |
UCL
- SSS/IREC/FATH - Pôle de Pharmacologie et thérapeutique UCL - SSS/IREC/CARD - Pôle de recherche cardiovasculaire UCL - (SLuc) Service de cardiologie UCL - (SLuc) Service de médecine interne et maladies infectieuses (MIMI) UCL - SSS/IREC - Institut de recherche expérimentale et clinique |
Links |
Bibliographic reference | Hermida Blanco, Nerea ; Markl, Andreas ; Hamelet, Julien ; Van Assche, Tim ; Vanderper, Annelies ; et. al. HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome. In: Cardiovascular Research, Vol. 99, no. 1, p. 44-54 (2013) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/131107 |